Loracarbef is a topic covered in the Johns Hopkins ABX Guide.
To view the entire topic, please sign in or purchase a subscription.
Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
FDA
- No longer available in the U.S.
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Acute otitis media
- Acute exacerbations of chronic bronchitis secondary bacterial infection of acute bronchitis
- Acute maxillary sinusitis
- Uncomplicated and complicated UTI.
- Pharyngitis/tonsillitis
- Community-acquired (CAP) caused by S. pneumoniae or H. influenzae (non-β-lactamase-producing strains only)
- Skin and skin-structure infections (impetigo)
-- To view the remaining sections of this topic, please sign in or purchase a subscription --
Last updated: October 5, 2015
Citation
* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Loracarbef
ID - 540323
A1 - Bartlett,John,M.D.
AU - Pham,Paul,Pharm.D.
Y1 - 2015/10/05/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540323/all/Loracarbef
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -